NCT07589621 Safety Behavior Fading Versus Progressive Muscle Relaxation for Appearance Concerns
| NCT ID | NCT07589621 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Florida State University |
| Condition | Body Dysmorphic Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2026-05-29 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2026-05-29 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The current study aims to explore the efficacy of a text message based safety behavior fading intervention compared to a progressive muscle relaxation intervention for appearance concerns.
Eligibility Criteria
Inclusion Criteria: * being between the ages of 18 and 65 years old * having an internet-capable smart-phone * scoring at or above the empirical cutoff for appearance concerns measured by the Social Appearance Anxiety Scale (i.e., 52) Exclusion Criteria: * changes in psychotropic medication in the last 4 weeks * failing attention checks in baseline data collection
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07589621 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Body Dysmorphic Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07589621 currently recruiting?
Yes, NCT07589621 is actively recruiting participants. Contact the research team at patel@psy.fsu.edu for enrollment information.
Where is the NCT07589621 trial being conducted?
This trial is being conducted at Tallahassee, United States.
Who is sponsoring the NCT07589621 clinical trial?
NCT07589621 is sponsored by Florida State University. The trial plans to enroll 300 participants.